Form 483

Jerome Stevens Pharmaceuticals, Inc. Form 483, 2015-07-23

FDA issued a Form 483 to Jerome Stevens Pharmaceuticals, Inc. on 2015-07-23 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

Jerome Stevens Pharmaceuticals, Inc. · Bohemia, United States · Issued July 23, 2015

Overview

  • 7 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Jul 2015
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Robert C Horan

23 Jul 2015
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Robert C Horan

23 Jul 2015
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Robert C Horan

23 Jul 2015
21 CFR 211.111

Deviations of production time limits

Cited by Robert C Horan

23 Jul 2015
21 CFR 211.194(a)

Complete test data included in records

Cited by Robert C Horan

Inspected site

JSJerome Stevens Pharmaceuticals, Inc.Bohemia, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.111Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere